PALI Stock Analysis: Buy, Sell, or Hold?
PALI - Palisade Bio, Inc. Common Stock
$1.83
0.02 (1.10%)
▲
5d:
+1.67%
30d:
-21.46%
90d:
+5.78%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When PALI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PALI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: PALI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: PALI is currently trading at $1.83, which is considered slightly low relative to its 30-day fair value range of $1.83 to $2.28.
Technical Outlook: Technically, PALI is showing sideways momentum. Immediate support is located at $1.76, while resistance sits at $2.21.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.71 (+430.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PALI is showing sideways momentum. Immediate support is located at $1.76, while resistance sits at $2.21.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.71 (+430.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.83 -
$2.28
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 430.8% below Wall St target ($9.71)
Trading Range Analysis
30-Day Trading Range
$1.83 -
$2.28
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.76
Resistance Level
$2.22
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.57
Wall Street Target
$9.71
(+430.8%)
Share & Embed Analysis
Last updated: May 18, 2026 8:06 AM ET
Data refreshes hourly during market hours. Next update: 9:06 AM
Data refreshes hourly during market hours. Next update: 9:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PALI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
John David Finley
SELL
3896 shares
2026-02-12
Mitchell Lawrence Jones
SELL
1989 shares
2026-02-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 48 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$106 | 56 HOLD |
